GLUE Competitors & Alternatives
Compare Monte Rosa Therapeutics Inc with similar stocks in the same industry
Biotechnology
GLUE
Main Stock$11.11
Tradestie Score
45
Market Cap
$463.20M
Revenue Growth
-0.6%
Analyst Upside
+141.9%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MDXG
MiMedx Group, Inc
|
$3.93
|
$1.01B | 93.5 | 48 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$3.73
|
$996.55M | - | 33 | Compare |
|
SYRE
Spyre Therapeutics, Inc. Common Stock
|
$92.33
|
$994.20M | - | 38 | Compare |
|
VALN
Valneva SE American Depositary Shares
|
$5.36
|
$993.46M | - | 52 | Compare |
|
IMNM
Immunome, Inc.
|
$18.26
|
$987.09M | - | 57 | Compare |
|
SANA
Sana Biotechnology, Inc. Common Stock
|
$2.37
|
$951.83M | - | 60 | Compare |
|
MNMD
Mind Medicine (MindMed) Inc. Common Shares
|
$15.02
|
$938.16M | - | 43 | Compare |
|
ZBIO
Zenas BioPharma, Inc. Common Stock
|
$28.23
|
$931.48M | - | 50 | Compare |
|
RLAY
Relay Therapeutics, Inc. Common Stock
|
$18.34
|
$917.23M | - | 47 | Compare |
|
BCAX
Bicara Therapeutics Inc. Common Stock
|
$17.61
|
$906.29M | - | 59 | Compare |
More GLUE Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2836)
219 stocks in this industry